CRP and interstitial lung disease: In line with the results presented in Table 6, PC-2 (associated mainly with CRP at the cut-off and its variants) (OR 3.0), but not PC-1 (associated mainly with blood counts), was associated with SSc-ILD in the presence of anti-Scl70+ (OR 19,1) and immunosuppressive treatment (OR 42.2).